Insmed INSM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$1.18B+7.3% | -$1.28B-7.9% | -$1.18B-14.5% | -$1.03B-2.1% | -$1.01B-10.9% | ||
| $11.5M+10.1% | $10.45M+25.8% | $8.3M+13.7% | $7.3M+16.8% | $6.26M+4.9% | ||
| $159.2M+4.3% | $152.71M+8.9% | $140.23M+4.4% | $134.34M+17.2% | $114.65M+18.4% | ||
| $5.78M-7.1% | $6.22M-5.6% | $6.59M-2.1% | $6.73M-1.8% | $6.86M-0.4% | ||
| $131.86M+49.3% | $88.31M+287% | $22.82M+80.7% | $12.63M+20.0% | $10.53M-18.6% | ||
| $32.38M+2.7% | $31.52M+44.1% | $21.88M+48.9% | $14.69M-15.9% | $17.47M+2.5% | ||
| $127.69M+27.6% | $100.07M+96.8% | $50.86M+744% | $6.02M-61.0% | $15.45M-65.4% | ||
| $14.65M+590% | $2.12M+117% | -$12.37M— | —— | —— | ||
| -$3.32M+33.5% | -$4.99M+42.3% | -$8.66M-5.8% | -$8.18M-2.6% | -$7.97M+33.3% | ||
| $20.77M+0.4% | $20.68M+1.3% | $20.41M-0.7% | $20.54M+1.5% | $20.25M+1.0% | ||
| $6.82M+13.6% | $6M+12.7% | $5.33M+5.4% | $5.05M0.0% | $5.05M0.0% | ||
| $186.73M-25.9% | $251.99M— | —— | —— | —— | ||
| -$895.66M+4.2% | -$935.01M-5.8% | -$883.4M-4.6% | -$844.55M-10.8% | -$761.94M-11.4% | ||
| $25.97M-20.2% | $32.56M+43.2% | $22.74M-5.3% | $24.02M-12.1% | $27.31M+24.6% | ||
| $1.65B-20.9% | $2.09B-11.8% | $2.37B— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.19B+7.6% | $1.11B+2.4% | ||
| $3.05M+3.1% | $2.96M+3.1% | $2.87M+3.2% | $2.78M+3.2% | $2.7M+3.3% | ||
| $954.59M+0.1% | $954.07M-11.6% | $1.08B-25.2% | $1.44B+5.6% | $1.37B+1.9% | ||
| —— | —— | —— | $2.23M+313% | $541K+141% | ||
| —— | —— | -$126.69M-438% | $37.53M+119% | -$192.48M-365% | ||
| $55.35M0.0% | $55.35M-3.0% | $57.08M+13.6% | $50.26M+10.5% | $45.48M+12.1% | ||
| $4.91M+18.4% | $4.14M-3.2% | $4.28M+12.9% | $3.79M+9.3% | $3.47M+38.7% | ||
| $5.78M-7.1% | $6.22M-5.6% | $6.59M-2.1% | $6.73M-1.8% | $6.86M-0.4% | ||
| $6.82M+13.6% | $6M+12.7% | $5.33M+5.4% | $5.05M0.0% | $5.05M0.0% | ||
| $186.73M-25.9% | $251.99M— | —— | —— | —— | ||
| $11.5M+10.1% | $10.45M+25.8% | $8.3M+13.7% | $7.3M+16.8% | $6.26M+4.9% | ||
| $23.9M-55.3% | $53.43M— | —— | —— | —— | ||
| $9.53M-1.2% | $9.65M+135% | $4.11M+15.6% | $3.55M— | —— | ||
| —— | —— | —— | —— | $0— | ||
| $3.05M+3.1% | $2.96M+3.1% | $2.87M+3.2% | $2.78M+3.2% | $2.7M+3.3% | ||
| $2.71M0.0% | $2.71M0.0% | $2.71M0.0% | $2.71M0.0% | $2.71M0.0% | ||
| $4.91M+18.4% | $4.14M-3.2% | $4.28M+12.9% | $3.79M+9.3% | $3.47M+38.7% | ||
| -$921.64M+4.7% | -$967.58M-6.8% | -$906.14M-4.3% | -$868.57M-10.0% | -$789.25M-11.8% | ||
| -$921.64M+4.7% | -$967.58M-6.8% | -$906.14M-4.3% | -$868.57M-10.0% | -$789.25M-11.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insmed generate?
- Insmed (INSM) generated -$895.7M in operating cash flow over the trailing twelve months.
- What is Insmed's free cash flow?
- After $26.0M of capital expenditures, Insmed's free cash flow was -$921.6M over the trailing twelve months, down 16.8% year over year.
- Where does Insmed's cash flow data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
